Lanreotide Powder Manufacturer China | CAS 108736-35-2 High Purity Somatostatin Analogue Peptide API Supplier

Core Selling Points

✅ ≥98% HPLC Purity Research‑Grade Peptide Material

✅ LC‑MS Full Cyclic Octapeptide Sequence & Disulfide Bond Verification

✅ Batch‑Specific COA, HPLC & MS Test Reports Available

✅ Optimized Fmoc SPPS Cyclization Workflow, In‑house Independent QC Laboratory

✅ Global Export Documentation & Cross‑border Cold‑chain Logistics Support

✅ Custom Peptide Purification & Salt‑form Adjustment Service

What Is Lanreotide Powder?

Lanreotide powder is a synthetic cyclic octapeptide somatostatin analogue, stabilized by an intramolecular disulfide bond. It exhibits high binding affinity toward somatostatin receptors SSTR2 and SSTR5, widely deployed for neuroendocrine tumor research, acromegaly mechanism studies, and hormone‑secretion inhibition preclinical projectsPMC.

Manufactured with optimized Fmoc solid‑phase peptide synthesis, controlled cysteine oxidative cyclization and multi‑stage gradient HPLC purification, our Lanreotide powder maintains correct disulfide‑bond configuration, stable biochemical performance and consistent batch‑to‑batch quality. HDM BIO serves global biotech labs and pharmaceutical R&D teams with lab‑scale sample supply and large‑volume bulk procurement. This peptide raw material is strictly limited to laboratory research use only and cannot be directly applied for human clinical administration.

What Are the Official Quality Specifications of Lanreotide Powder?

Each production batch of Lanreotide undergoes dual QC testing (HPLC + LC‑MS) within HDM BIO analytical laboratory. Exclusive batch COA will be issued for all bulk procurement orders.

Item	Specification	Result
Appearance	White to off-white powder	Consistent
Purity (HPLC)	≥98%	99.66%
MS Identity	Consistent with reference standard	Confirmed
Conclusion	Cosmetic raw material requirement	Passed

Lanreotide vs Other Somatostatin Analogue Peptides

For buyers sourcing cyclic peptides for neuroendocrine and endocrine pharmacology research, this comparison clarifies core differences for targeted raw‑material selection:

Product	Target Mechanism	Structural Feature	Primary Research Application	CAS Number
Lanreotide	SSTR2 / SSTR5 agonist; suppresses GH, IGF‑1 and tumor‑related hormone release	Cyclic octapeptide, disulfide‑bond stabilized	Neuroendocrine tumor, acromegaly pre‑clinical research	108736‑35‑2
Octreotide Acetate	SSTR2 / SSTR5 agonist	Cyclic octapeptide somatostatin analogue	Comparative SSTR pharmacology, gastro‑entero‑pancreatic tumor study	83150‑76‑9
Pasireotide	Broad‑spectrum SSTR1‑3, SSTR5 high‑affinity agonist	Cyclic hexapeptide	Cushing's disease, multi‑receptor somatostatin pathway research	396091‑73‑9

This section covers long‑tail keywords: lanreotide vs octreotide, lanreotide vs pasireotide, somatostatin analogue peptide raw material.

How to Buy Lanreotide Powder from a Reliable Supplier?

When sourcing Lanreotide powder for endocrine pharmacology and neuroendocrine disease research, R&D teams and international peptide buyers should evaluate five critical criteria to avoid quality and supply risks:

HPLC purity validation: Confirm ≥98% purity alongside complete impurity chromatogram
LC‑MS structural confirmation: Verify full octapeptide sequence and correct disulfide‑bond cyclization
Batch‑specific documentation: Guarantee each order can be matched with independent COA reports
Mature synthesis capability: Select suppliers with proven experience producing cyclic disulfide‑containing octapeptides
Global export service: Verify suppliers can provide full supporting documents for customs clearance worldwide

HDM BIO supplies research‑grade Lanreotide with full quality records, flexible minimum order quantity and worldwide shipping for small trial batches and long‑term bulk procurement.

Lanreotide Powder Price & Bulk Ordering Guide 2026

Buyers searching for Lanreotide powder price, bulk peptide quotation and delivery terms can refer to key procurement information below:

Minimum Order Quantity: Flexible MOQ, milligram & gram‑level trial samples available; kilogram bulk supply for continuous research projects
Sample Pricing: Trial samples for laboratory assessment; contact sales team to acquire sample quotation
Bulk Kilogram Quotation: Tiered pricing policy, larger bulk orders enjoy competitive unit cost
Production Lead Time: Standard lead time depends on order volume; sales will confirm exact production schedule upon formal inquiry
Shipping Options: Cold‑chain transportation to maintain cyclic peptide stability; we provide commercial invoice, packing list and MSDS for global customs clearance

Multiple factors influence the final quotation: purity grade, customized testing requirements, special packaging specifications and cold‑chain logistics fees. Contact our sales team for up‑to‑date formal quotation.

Lanreotide Powder Procurement Guide for Global Buyers

Before signing purchase contracts for cyclic disulfide‑containing peptide raw materials, international procurement teams should complete these verification steps to mitigate potential risks:

Supplier verification: Confirm the supplier owns independent peptide synthesis workshop and in‑house QC laboratory
Document inspection: Request pre‑shipment batch COA, HPLC chromatogram and LC‑MS identity report
Product confirmation: Check peptide purity standard, disulfide‑bond integrity and storage specifications match your experimental design
MOQ & lead time: Confirm stock availability, production cycle and order adjustment policy
Shipping documents: Confirm the supplier can provide all required files for import customs clearance in your region

About HDM BIO Lanreotide Manufacturing Capability

HDM BIO owns over 10 years of experience focused on Fmoc solid‑phase peptide synthesis and complex cyclic peptide raw material manufacturing.

Dedicated SPPS production lines optimized for cysteine‑rich cyclic octapeptides requiring controlled oxidative cyclization
Independent analytical laboratory equipped with HPLC, LC‑MS, moisture tester and heavy‑metal testing instruments
Peptide products exported to more than 70 countries, serving university labs, biotech startups and pharmaceutical R&D institutes
Stable annual production capacity for research‑grade peptide raw materials, supporting long‑term framework cooperation
Professional technical team with rich experience in cyclic peptide cyclization, purification and stereochemistry control

Our peptide manufacturing facility operates dedicated Fmoc SPPS production lines with in‑house HPLC purification and LC‑MS analytical capability.

What Technical Challenges Exist in Lanreotide Synthesis & Production?

Lanreotide is a cyclic octapeptide containing one intramolecular disulfide bridge, with D‑configured unnatural amino acids within its sequence. Stereochemical control and selective cyclization represent major technical barriers separating qualified peptide manufacturers from low‑grade suppliersPMC.

Core production difficulties include:

Controlling epimerization risk of D‑amino‑acid residues during stepwise coupling
Avoiding intermolecular dimer formation during oxidative cyclization, favoring intramolecular ring closure
Separating hard‑to‑remove epimer and mis‑cyclized peptide impurities
Guaranteeing full‑length sequence integrity without truncated deletion by‑products
Reproducible batch‑to‑batch disulfide‑bond configuration and biochemical properties

HDM BIO adopts optimized coupling parameters, controlled oxidative folding protocols, multi‑stage gradient HPLC purification and full‑process LC‑MS monitoring for each batch. This minimizes epimeric and mis‑cyclized impurities and guarantees intact cyclic octapeptide structure and stable batch‑to‑batch quality.

How Does Lanreotide Work in Laboratory Research?

As a synthetic somatostatin‑receptor agonist, Lanreotide powder binds selectively to SSTR2 and SSTR5 receptors on target cells. In pre‑clinical research models it suppresses secretion of growth hormone, IGF‑1 and multiple tumor‑derived hormones, induces cell‑cycle arrest and modulates neuroendocrine signaling cascadesPMC.

It serves as a key experimental reference compound for neuroendocrine tumor mechanism research, acromegaly in‑vitro assays and somatostatin‑receptor drug candidate evaluation. All mechanism descriptions apply only to in‑vitro and pre‑clinical animal research scenarios.

How Is Lanreotide Powder Manufactured at HDM BIO?

Lanreotide requires strict process control over amino‑acid coupling, selective oxidative cyclization and impurity removal to achieve the correct cyclic tertiary structure.

Read related guide: Modified Peptide API Manufacturing Guide | Fmoc SPPS Technology Explained

Complete Lanreotide Manufacturing Workflow

Raw Material Inspection → Octapeptide SPPS Stepwise Coupling → Resin Cleavage & Global Deprotection → Controlled Oxidative Cyclization → Multi‑stage HPLC Purification → Vacuum Lyophilization → Full QC Testing → Batch COA Issuance → Sealed Light‑Proof Packaging

QC Inspection Workflow

Incoming Raw Material QC → In‑process coupling & cyclization monitoring → HPLC Purity Testing → Mass Spectrometry Identity Verification → Disulfide‑bond mapping → Moisture & Heavy‑Metal Testing → Residual Solvent Detection → Final Batch Release Approval

Core Process Highlights

Optimized coupling conditions to reduce D‑amino‑acid epimerization impurities

Controlled oxidative cyclization to minimize peptide dimer by‑products

Multi‑stage high‑precision HPLC purification removes epimeric and mis‑cyclized variants

Full‑structure LC‑MS verification confirms intact cyclic octapeptide chain

Vacuum lyophilization and light‑proof sealed packaging preserve cyclic peptide stability during transport and low‑temperature storage

What Are the Main Application Scenarios of Lanreotide Powder?

Endocrine pharmacology research: Somatostatin receptor signaling, growth‑hormone and IGF‑1 secretion‑inhibition experiments
Neuroendocrine tumor pre‑clinical study: Gastroenteropancreatic NET mechanism and anti‑tumor compound screening
Acromegaly model research: Pituitary hormone dysregulation pathway investigation
Biomedical reagent preparation: Laboratory reference standards and experimental control reagents
Peptide formulation research: Long‑acting depot peptide formulation development

Why Choose HDM BIO As Your Lanreotide Powder Supplier?

10+ years of professional cyclic & modified peptide raw‑material manufacturing experience in China
Mature process for cyclic octapeptides with disulfide‑bond cyclization and epimer control
Strict full‑structure verification and batch stability control for every production lot
Complete production traceability records for each batch of Lanreotide
Flexible supply: gram‑level lab samples to kilogram‑level bulk peptide orders
Global export service covering more than 70 countries and regions
Professional technical team supporting somatostatin‑pathway peptide research consulting

FAQs About Lanreotide Powder

Q: Where can I buy Lanreotide powder from China?

A: HDM BIO is a China‑based cyclic peptide supplier providing high‑purity Lanreotide powder for global pharmaceutical R&D teams and biotech laboratories. We offer small research samples and large bulk orders, supported by complete export documents and worldwide shipping.

Q: What documents should a qualified Lanreotide supplier provide?

A: Reliable suppliers can offer batch‑specific COA, HPLC purity chromatogram, LC‑MS identity verification report, MSDS and complete production traceability records for quality audit and customs clearance.

Q: What is the CAS number of Lanreotide?

A: The CAS registry number of Lanreotide is 108736‑35‑2.

Q: What purity grade of Lanreotide powder can you supply?

A: Standard research grade ≥98% HPLC purity. Higher purity specifications can be customized for special experimental requirements.

Q: How should lyophilized Lanreotide powder be stored?

A: Store sealed at ‑20 °C, protected from light and moisture. Avoid repeated freeze‑thaw cycles to maintain cyclic peptide structural stability.

Q: Can I obtain Lanreotide samples before bulk cooperation?

A: Yes. We provide milligram to gram‑level trial samples attached with complete COA and test documents for laboratory evaluation.

Q: What is the MOQ for bulk Lanreotide powder?

A: MOQ is flexible based on purity grade and packaging requirements. We support small research batches and large‑scale bulk orders to satisfy different project demands.

Q: What is the amino‑acid sequence of Lanreotide?

A: D‑βNal‑Cys‑Tyr‑D‑Trp‑Lys‑Val‑Cys‑Thr‑NH₂, cyclic via disulfide bridge between Cys2 and Cys7.

Scientific Review

Reviewed by: HDM BIO Peptide Technical Team Expertise: Peptide synthesis Cyclic & disulfide‑containing peptide manufacturing Analytical chemistry & HPLC/LC‑MS testing

Last Updated: August 2026

Disclaimer: All product content is provided for academic research and laboratory raw‑material reference only. Not intended for human clinical use, diagnosis or treatment.